Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating prosopalgia

A technology for trigeminal neuralgia and drugs, which is applied in drug combinations, nervous system diseases, antipyretics, etc., can solve problems such as unsatisfactory curative effect, high treatment cost, and large side effects, and achieve scientific and reasonable drug formula, significant curative effect, and effective fast effect

Inactive Publication Date: 2016-01-13
杨秀芹
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Western medicine believes that trigeminal neuralgia is episodic facial pain with unknown etiology, and the main treatments are drug therapy and surgical therapy; drugs such as carbamazepine and olanzapine are mainly used for treatment, but the curative effect is not ideal, the side effects are large, and the treatment cost is high. High; although surgical treatment has achieved a certain effect, it is easy to leave sensory disturbances such as facial numbness and swelling, which is difficult for patients to accept
There are also various traditional Chinese medicines for the treatment of trigeminal neuralgia on the market, but the curative effect is not satisfactory. Therefore, people have a great demand for Chinese medicines for the effective treatment of trigeminal neuralgia.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] A medicine for treating trigeminal neuralgia, which comprises the following raw materials by weight: 30 parts of white aconite, 4 parts of arachis, 5 parts of vitex, 3 parts of asarum, 10 parts of flying sword, and 20 parts of turmeric , 10 parts of silkworm, 4 parts of gardenia, 20 parts of cistanche, 10 parts of Eucommia, 10 parts of Chuanxiong, 30 parts of wolfberry, 20 parts of Polygonum multiflorum, 10 parts of Ziheche, 6 parts of Radix Ophiopogon japonicus, 3 parts of Piperumba, 8 parts of corrugated seeds 8 parts, 8 parts of medlar, 10 parts of Yu Liren.

[0034] The preparation method of above-mentioned medicine is as follows:

[0035] Take the raw medicinal materials of the prescribed amount, chop or crush them appropriately, put them in a suitable decoction container, add 1000-1200ml of water to immerse the medicinal materials, soak for 1.5-2 hours, heat to boiling, and decoct for 30 minutes, then separate the decocted liquid, Add 800ml of water to the medici...

Embodiment 2

[0037] A medicine for treating trigeminal neuralgia, which comprises the following raw materials by weight: 50 parts of white aconite, 6 parts of arachis, 12 parts of vitex, 8 parts of asarum, 20 parts of flying sword, and 30 parts of turmeric , 20 parts of silkworm, 8 parts of gardenia, 30 parts of Cistanche, 20 parts of Eucommia, 20 parts of Chuanxiong, 50 parts of wolfberry, 30 parts of Polygonum multiflorum, 20 parts of Ziheche, 14 parts of Radix Ophiopogon, 5 parts of Piperumba, 12 parts of corrugated seeds 12 parts, 12 parts of medlar, 15 parts of Yu Liren.

[0038] The preparation method of above-mentioned medicine is the same as embodiment 1.

Embodiment 3

[0040] A medicine for treating trigeminal neuralgia, which comprises the following raw materials by weight: 40 parts of white aconite, 8 parts of arachis, 9 parts of vitex, 6 parts of asarum, 15 parts of flying sword, and 25 parts of turmeric , 15 parts of silkworm, 6 parts of gardenia, 25 parts of Cistanche, 15 parts of Eucommia, 15 parts of Chuanxiong, 40 parts of wolfberry, 25 parts of Polygonum multiflorum, 15 parts of Ziheche, 10 parts of Ophiopogon japonicus, 4 parts of Piper barbatus, 10 parts of corrugated fruit 10 parts, 10 parts of medlar, 12 parts of Yu Liren.

[0041] The preparation method of above-mentioned medicine is the same as embodiment 1.

[0042] Summary of clinical efficacy:

[0043] 1. Clinical data: 300 patients with trigeminal neuralgia were selected as outpatients, the oldest was 65 years old, the youngest was 42 years old, and the average age was 47.9 years old.

[0044] 2. Diagnostic criteria: ① episodic pain; ② pain strictly limited to the distri...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicine for treating prosopalgia, belonging to the technical field of traditional Chinese medicines. The medicine is prepared from processed rhizoma typhonii, processed rhizoma arisaematis, fructus viticis, asarum, polypodiaceae pyrrosia lingua, curcuma aromatica, bombyx batryticatus, cape jasmine, cistanche deserticola, eucommia ulmoides, rhizoma chuanxiong, the fruits of Chinese wolfberry, polygonum multiflorum, placenta hominis, radix ophiopogonis, piper longum, concha arcae, fruits of Chinese holly and bunge cherry seeds at a certain weight ratio. Through the synergistic effect of the medicinal materials, the medicine has the efficacies of soothing liver-qi stagnation, tonifying liver and kidney, warming and activating meridian, reinforcing qi and nourishing blood, as well as clearing damp and dispelling cold, can effectively treat prosopalgia without relapse of prosopalgia, and belongs to a good medicine for treating prosopalgia.

Description

technical field [0001] The invention discloses a medicine for treating trigeminal neuralgia, which belongs to the technical field of traditional Chinese medicine. Background technique [0002] Trigeminal neuralgia is a common clinical disease, which is defined by the International Headache Society as "a unilateral disease limited to the distribution area of ​​one or more branches of the trigeminal nerve, characterized by sudden onset, short-term electric shock-like pain" of TN The annual incidence rate is about 3-5 / 100,000 people, more onset after the age of 40, more middle-aged and elderly people, and more women than men. Trigeminal neuralgia is divided into primary trigeminal neuralgia and secondary trigeminal neuralgia. The primary etiology and pain mechanism are unknown. At present, there are two theories of pathogenesis: one is the theory of central lesions, which is caused by similar epileptic activities in the central pathway of the trigeminal nerve; Disease factor...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/9066A61P25/02A61P29/00A61K35/50A61K35/618A61K35/64
Inventor 杨秀芹
Owner 杨秀芹
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com